We see beneath the skin to improve patient care, save costs and lives.

DeepX AI is augmented by satellite technology.

DeepX's patented Optical Transfer Diagnosis (OTD) technology is inspired by our founders work on NASA satellite imaging technology.

Our solution maps biological components under the skin to diagnose skin health through “optical biopsies”. DeepX Health’s technology empowers unparalleled AI diagnosis of skin cancer​.

Primary care physicians struggle with skin conditions and skin cancer.

skin-cancer

1/5

Americans will develop skin cáncer in their lifetime.

melanoma

20

Nearly 20 Americans die from melanoma each day.

biopsies

15M

Estimated biopsies for skin cancer annually in the USA.

positive

1/25

Only 1 in 25 biopsies for melanoma are positive.

DermoSight™

An Improvement to the Traditional Approach

Traditional approach

35 days

  • visual

    Visual skin examination by primary care physician.

  • specialist

    Suspicious lesions are referred to specialist.

  • time

    Waiting times for dermatologist appointment in the USA average 34.5 days.

DermoSight Solution

1-2 days

  • remote

    Primary Care consultations through DermoSight are triaged by a remote specialist.

  • assessment

    All lesions are reviewed by remote specialist and the patient receives assessment within 24-48 hours.

  • ai

    Future
    DermoSight is ready for DeepX AI assessment.

Dermosight™

A proven dermoscopy solution

Over 250,000 commercial evaluations in Europe to date, primarily in a retail pharmacy setting.

  • Available across 5 different countries in Europe.

  • Available in 250 pharmacies.

  • 99% of patient felt the pharmacy was a suitable venue.

A solution for everyone

1

Consultation

Patient

Patient just walks into any health system for quick assessment. No need for an appointment with a doctor.

2

Assessment

Health System

3

Diagnosis

Doctors and Providers

Developing AI the right way

We are committed to developing our DeepX AI algorithm in a responsible and ethical manner:

  • Best Practices

    We are following best practices for the development and use of AI to ensure that our algorithm is safe, accurate, and fair.

  • Collecting our own data

    We are collecting all our own data in collaboration with the dermatology community to ensure its quality and our complete control over the data.

  • Consent and data privacy

    We received consent from all patients whose lesion images are being used to develop the algorithm. This is important to protect patient privacy and to ensure that patients are aware of how their data will be used.

  • Diversity

    We are committed to gathering diverse data from a wide range of patient demographics, ensuring that our AI is trained and validated on a broad spectrum of skin types, ages, and conditions for accurate and inclusive diagnostics.

  • Expert input

    We actively seek out input from experts in the field and are open to feedback.

Long term horizon

DeepX Health technologies are suitable for use in other medical areas.

Top stakeholders can benefit significantly from the value of our dataset and technology.

Database

More than 200,000 proprietary images of skin lesions with medical reports for R&D. Dataset is growing daily by virtue of our telederm service. Data mining and optimization for R&D purposes can be explored.

Cosmeceutical

DeepX Health technology can be utilized for cosmeceutical companies to market the effect of cosmetic products.

Pharmaceutical

DeepX Health technology can be utilized for monitoring PDT (photodynamic therapy) and other skin treatments, as well as opening further oncology diagnostic and therapeutic opportunities.

Insurance

DeepX Health technology can help insurance companies reduce costs by improving diagnostic quality of care.

Why choose DermoSight™

Why choose DermoSight™

The DermoSight Solution has been running in a medium sized CCG since 2020. Over a 12-month period we have collated the data found from utilising our solution. 88% of all submissions were considered appropriate for management in primary care.

Download

User quotes

"I want everyone to know about this fantastic service."

I had a mole on my Left Arm that was darker than the other moles on my body. I decided to get it scanned. I received a call from DeepX to explain what the Dermatologist found and what to do next. I got my mole removed from the NHS, and it was confirmed Melanoma. I received a follow-up call months later from DeepX. I am so impressed with the service and support I received. I have told all my friends and family.

Ms R

London – September 2023

We would love to hear from you!